首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Comparative in vitro surveillance of amoxicillin-clavulanic Acid and four oral comparators against 21,232 clinical isolates from europe.
【24h】

Comparative in vitro surveillance of amoxicillin-clavulanic Acid and four oral comparators against 21,232 clinical isolates from europe.

机译:阿莫西林-克拉维酸和四个口服比较剂对来自欧洲的21,232株临床分离株的体外比较监测。

获取原文
获取原文并翻译 | 示例
       

摘要

The present study was conducted to determine the in vitro activity of amoxicillin-clavulanic acid compared to that of four newer antimicrobial agents (ampicillin, azithromycin, cefuroxime and trimethoprim-sulfamethoxazole). All of the agents were tested against 21,232 recent clinical isolates encompassing 37 species submitted from 16 European countries between 1997 and 1999. After 20 years of clinical use, amoxicillin-clavulanic acid continues to retain much of its initial activity against targeted gram-positive organisms, selected gram-negative organisms and major respiratory pathogens.
机译:进行本研究是为了确定阿莫西林-克拉维酸与四种新型抗菌剂(氨苄青霉素,阿奇霉素,头孢呋辛和甲氧苄氨嘧啶-磺胺甲恶唑)相比的体外活性。在1997年至1999年之间,针对所有试剂对21 232种最近的临床分离株进行了测试,其中包括16个欧洲国家/地区提交的37种。经过20年的临床使用,阿莫西林-克拉维酸继续保留其针对靶向革兰氏阳性生物的大部分初始活性,选定的革兰氏阴性菌和主要的呼吸道病原体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号